Liver transplantation and primary liver cancer in porphyria
Liver International · 2025
DOI: 10.1111/liv.15894 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Mattias Lissing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology Division, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Neoplasms, Porphyria, Acute Intermittent, Porphyrias. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The porphyrias are a heterogeneous group of metabolic disorders that result from defects in heme synthesis. The metabolic defects are present in all cells, but symptoms are mainly cutaneous or related to neuropathy. The porphyrias are highly relevant to hepatologists since patients can present with symptoms and complications that require liver transplantation (LT), and some porphyrias are associated with a high risk for primary liver cancer (PLC). Among the cutaneous porphyrias, erythropoietic protoporphyria (EPP) can lead to cholestatic liver failure where LT cures the liver disease but not the porphyria. In acute porphyria (AP), neurotoxic porphyrin precursors are produced in the liver and LT is a curative treatment option in patients with recurrent severe neuropathic attacks. Patients with AP, mainly acute intermittent porphyria, have a significantly increased risk for PLC that warrants surveillance and adequate follow‐up of high‐risk groups. LT is well established in both EPP with liver failure and AP with recurrent attacks, but most transplant centres have little porphyria experience and cooperation between transplant hepatologists, and porphyria experts is important in the often‐difficult decisions on timing and management of comorbid conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatology Division, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine and Division of Gastroenterology, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Mattias Lissing
Zitieren
APA
Lissing, M., Wang, B., & Wahlin, S. (2025). Liver transplantation and primary liver cancer in porphyria. Liver International. https://doi.org/10.1111/liv.15894
Vancouver
Lissing M, Wang B, Wahlin S. Liver transplantation and primary liver cancer in porphyria. Liver International. 2025. doi:10.1111/liv.15894
BibTeX
@article{Lissing2025,
author = {Lissing, Mattias and Wang, Bruce and Wahlin, Staffan},
title = {Liver transplantation and primary liver cancer in porphyria},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.15894}
}
EUVIMED